1345955-99-8

Basic information

• Product Name: 7-chloro-2-(4-hydroxyphenyl)-pyrido[3,2-d]pyrimidine
• Synonyms: 7-chloro-2-(4-hydroxyphenyl)-pyrido[3,2-d]pyrimidine
• CAS NO: 1345955-99-8
• Molecular Weight: 257.679
• Mol File: 1345955-99-8.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 7-chloro-2-(4-hydroxyphenyl)-pyrido[3,2-d]pyrimidine(CAS DataBase Reference)
• NIST Chemistry Reference: 7-chloro-2-(4-hydroxyphenyl)-pyrido[3,2-d]pyrimidine(1345955-99-8)
• EPA Substance Registry System: 7-chloro-2-(4-hydroxyphenyl)-pyrido[3,2-d]pyrimidine(1345955-99-8)

Safety Data

• Hazardous Substances Data: 1345955-99-8(Hazardous Substances Data)

Downstream Products

• 1345956-47-9 7-chloro-2-(4-methoxymethoxy-phenyl)-pyrido[3,2-d]pyrimidine 
• 1345956-48-0 N-[2-(4-methoxymethoxy-phenyl)-pyrido[3,2-d]pyrimidin-7-yl]-nicotinamide 
• 1345956-51-5 N-[2-(4-hydroxy-phenyl)-pyrido[3,2-d]pyrimidin-7-yl]nicotinamide 
• 1345956-14-0 2-(4-hydroxyphenyl)-7-((6-methoxy)-pyridin-3-yl)-pyrido[3,2-d]pyrimidine 
• 1345956-26-4 2-(4-hydroxyphenyl)-7-(4-formylphenyl)-pyrido[3,2-d]pyrimidine 
• 1345956-31-1 2-(4-hydroxyphenyl)-7-(2-benzothiazolamino)-pyrido[3,2-d]pyrimidine 
• 1345956-62-8 4-(7-(5-(morpholinomethyl)thiophen-3-yl)pyrido[3,2-d]pyrimidin-2-yl)phenol 
• 1345956-21-9 2-(4-hydroxyphenyl)-7-((4-formyl)thiophen-3-yl)-pyrido[3,2-d]pyrimidine 
• 1345956-61-7 4-(7-(5-(piperidin-1-ylmethyl)thiophen-3-yl)pyrido[3,2-d]pyrimidin-2-yl)phenol 
• 1345956-35-5 2-(4-hydroxyphenyl)-7-(4-methoxyphenylamino)-pyrido[3,2-d]pyrimidine 
• 1345956-42-4 2-(4-hydroxyphenyl)-7-(4-hydroxyphenylamino)-pyrido[3,2-d]pyrimidine 
• 1345956-41-3 2-(4-hydroxyphenyl)-7-(2-pyridinylamino)-pyrido[3,2-d]pyrimidine 
• 1345956-40-2 2-(4-hydroxyphenyl)-7-(3-pyridinylamino)-pyrido[3,2-d]pyrimidine 
• 1345956-39-9 2-(4-hydroxyphenyl)-7-(4-pyridinylamino)-pyrido[3,2-d]pyrimidine 

Relevant articles and documents

DERIVATIVES OF PYRIDO [3,2-D] PYRIMIDINE, METHODS FOR PREPARATION THEREOF AND THERAPEUTIC USES THEREOF

The present invention relates to a compound of the following general formula (I): wherein: R1 is notably H, a halogen or an aryl group,R2 is notably a halogen or an aryl group,R3 is notably a halogen, or an aryl or heteroaryl group, as well as to its pharmaceutically acceptable salts, its hydrates or its polymorphic crystalline structures, its racemates, diastereoisomers or enantiomers, except the compound 1-(2,4-diaminopyrido[3,2-d]pyrimidin-7-yl)-3,6,6-trimethyl-6,7-dihydro-1H-indol-4(5H)-one.